Sign up or log in to see what your friends are attending and create your own schedule!

View analytic


Emerging therapies for brain and retinal diseases
    Thursday July 12, 2012 1:15pm - 2:45pm @ Wicklow Hall 2A

    Diseases of the brain and retina are notoriously difficult to treat. An estimated 98% of EMEA/FDA-approved drugs that could have potential to treat conditions ranging from Alzheimer disease (AD) to Grade IV brain tumours that do not easily cross the blood vessels in the brain and retina. Moreover, as is the case in age-related macular degeneration (AMD), regular and costly injections of therapeutics directly into the globe of the eye carry risks of infection and serious adverse effects.
    Here, we will present information on the emerging therapies that are being developed here in Ireland, Europe and the US with regard to the treatment of debilitating diseases of the retina such as AMD and retinitis pigmentosa (RP). This session aims to inform the public on how emerging medicines are being developed and the promise that these medicines hold for diseases of the brain and retina.

    Duke University, USA

    Beaumont Hospital, Ireland

    Trinity College Dublin, Ireland

    Institute of Ophthalmology, UK

    Type Science Programme, The Future of Medicine & Health
    Host Organization Trinity College Dublin, Ireland
  • Organiser Matthew Campbell
  • Tags SP19

Sign up or log in to save this event to your list and see who's attending!


Share on
Facebook Twitter
Take A Tour Of Site Features

Get Adobe Flash player